Novartis News — every source, one live feed
Track Novartis news in real time — Swiss drugmaker focused on innovative medicines in cardiology, oncology, and immunology.. fllwup^ collects the latest Novartis headlines from every major source into one live feed — free, no account, no algorithm. Coverage aggregated from BBC, Reuters, AP, NYT, TechCrunch, Al Jazeera, and 200+ other outlets.
Latest Novartis headlines
- Novartis CEO argues shareholders ‘happy overall’ with strategy, calls for COINS Act adjustment — Fierce Biotech
- Novartis CEO, staring down $16.7B post-2030 patent cliff, challenges Wall Street consensus — Fierce Pharma
- Novartis Unveils Mid-Term Financial Guidance Backed by 35+ Potentially Submission-Enabling Pipeline Readouts — Benzinga
- Novartis Trims Sales-Growth Outlook Before Investor Meeting — Bloomberg.com
- Novartis projects slowed growth, pins hopes on billions in pipeline potential — BioSpace
- Novartis Raises Peak-Sales Guidance for Three Key Brands — TipRanks
- Novartis raises forecasts for three key growth products — pharmaphorum
- Anthropic board director Vas Narasimhan bets AI can help Novartis solve ‘biological latency’ — Fierce Biotech
- Cosentyx bags FDA nod for 11th indication as Novartis looks to buffer 2029 patent cliff — Fierce Pharma
- Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy — STAT
Follow Novartis live on fllwup^ · Follow in any RSS reader — or browse all topics.
More Global Stocks & ADRs: browse the category. Compare: fllwup^ vs Flipboard · vs Feedly · vs Google News · vs Apple News.